Professional Documents
Culture Documents
STORAENSO RESULTS Key Figures 2018
STORAENSO RESULTS Key Figures 2018
TRI (Total recordable incidents) rate = number of incidents per one million hours worked.
1
Q2/2017 is restated due to a change in the Group’s operational EBITDA definition
to include the operational EBITDA of its equity accounted investments (EAI). See the
chapter Change in the operational EBITDA definition in the beginning of the
Financials section.
2
For Stora Enso employees. As of January 2018, Stora Enso’s joint operations Veracel and Montes del Plata are included in the Group’s consolidated safety performance. 2017 figures restated accordingly for comparability.
Attributable to:
Owners of the Parent 304 174 214 1013 625
Non-controlling interests -5 -1 -10 -24 -11
Net Profit for the Period 299 173 204 988 614
EUR million
Cash Flow from Operating Activities
Operating profit
Hedging result from OCI
Adjustments for non-cash items
Change in net working capital
Cash Flow Generated by Operations
Net financial items paid
Income taxes paid, net
Net Cash Provided by Operating Activities
Acquisitions
Cash and cash equivalents, net of bank overdrafts
Intangible assets and property, plant and equipment
Operating working capital
Tax assets and liabilities
Interest-bearing assets and liabilities
Fair value of Net Assets Acquired
Disposals
Other intangible assets, property, plant and equipment and biological assets
Working capital
Interest-bearing assets and liabilities
Non-controlling interests
Net Assets in Divested Companies
Gain on sale excluding CTA release and transaction costs
Total Disposal Consideration
1390 904
0 -
404 551
-428 37
1365 1492
-121 -193
-152 -97
1092 1202
-4 0
-29 -9
-3 -8
42 -4
3 5
1 -
9 45
0 -15
-525 -658
8 -52
-497 -696
578 425
-358 -1034
39 76
-323 -292
-2 -
-2 -1
-5 -3
-73 -829
521 -323
4 -23
603 949
1128 603
1130 607
-1 -4
1128 603
1
0
0
1
0
2 0
38 3
-2 1
- -1
-1 -
38 10
6 -9
44 1
44 -
- 1
44 1
- 3
the end of December 2018.
Assets
Biomaterials division
Paper division
Other
EUR million 2018 Q4/18 Q3/18 Q2/18 Q1/18 2017 Q4/17 Q3/17 Q2/17 Q1/17
Consumer Board 2622 637 648 691 646 2516 636 639 630 611
Packaging Solutions 1344 352 330 329 333 1255 334 318 313 290
Biomaterials 1635 415 413 413 394 1483 364 379 371 369
Wood Products 1622 399 400 430 393 1669 398 415 440 416
Paper 3066 761 779 754 772 2920 726 727 719 748
Other 3425 913 831 844 838 2490 618 593 628 651
Inter-segment sales -3229 -820 -815 -797 -797 -2288 -565 -562 -573 -588
Total 10486 2657 2585 2664 2579 10045 2511 2509 2528 2497
EUR million 2018 Q4/18 Q3/18 Q2/18 Q1/18 2017 Q4/17 Q3/17 Q2/17 Q1/17
Consumer Board 231 24 50 65 91 285 69 86 69 61
Packaging Solutions 245 59 68 57 61 170 58 48 40 24
Biomaterials 427 91 125 109 102 264 61 88 62 53
Wood Products 165 42 48 47 29 111 25 29 35 22
Paper 234 45 65 54 69 128 46 29 11 42
Other 23 9 2 -5 17 46 21 10 2 13
Operational EBIT 1,325 271 358 327 369 1,004 280 290 219 215
Fair valuations and non-operational items1 45 37 5 17 -14 -16 -15 0 -6 5
Items affecting comparability 20 47 0 -28 0 -84 -29 -20 -8 -27
Operating Profit (IFRS) 1,390 356 363 317 355 904 236 270 205 193
Net financial items -180 -41 -58 -60 -22 -162 -27 -46 -60 -29
Profit before Tax 1,210 315 305 257 333 742 208 224 145 164
Income tax expense -221 -16 -101 -44 -60 -128 -35 -33 -2 -57
Net Profit 988 299 204 213 273 614 173 191 143 107
1
Fair valuations and non-operational items include equity incentive schemes and related hedges, CO 2 emission rights, valuations of biological assets, and the group’s share of tax and net financial items of EAI.